The four other shortlisted candidates for COVID-19 vaccine development are: Oxford-AstraZeneca group, Johnson & Johnson, Merck and Pfizer. Fauci, while sounding an optimist note during a medical seminar on Tuesday, said the "winner or winners" among the shortlisted group may produce millions of doses by early 2021.